中华器官移植杂志
中華器官移植雜誌
중화기관이식잡지
CHINESE JOURNAL OF ORGAN TRANSPLANTATION
2011年
6期
347-350
,共4页
李瑞东%董家勇%殷浩%马钧%傅志仁%王正昕
李瑞東%董傢勇%慇浩%馬鈞%傅誌仁%王正昕
리서동%동가용%은호%마균%부지인%왕정흔
肝移植%免疫监测%泛耐药%鲍曼不动杆菌%感染
肝移植%免疫鑑測%汎耐藥%鮑曼不動桿菌%感染
간이식%면역감측%범내약%포만불동간균%감염
Liver transplantation%Immune monitoring%Pan-drug resistance%Acinetobacter baumannii%Infection
目的 探讨肝移植后泛耐药鲍曼不动杆菌(PDR-Ab)感染者的细胞免疫功能监测及免疫抑制方案的调整.方法 回顾性总结2008年1月至2010年5月299例尸体肝移植病例并发PDR-Ab的感染和预后情况.监测肝移植后T淋巴细胞亚群及绝对计数、CD4+T淋巴细胞ATP含量,进行T淋巴细胞免疫功能评分.将14例发生PDR-Ab感染者根据免疫抑制方案的调整不同分为2组,常规治疗组(6例)的他可莫司用量不变,停用吗替麦考酚酯和泼尼松,给予头孢哌酮钠/舒巴坦钠静脉滴注;免疫调节组(8例)在常规治疗的基础上,根据受者的T淋巴细胞免疫功能评分(TCIFS)的动态变化进行免疫抑制方案的调整.结果 两组间受者的年龄、终末期肝病模型评分、Child-Pugh评分的差异均无统计学意义(P>0.05);术中出血量的差异有统计学意义(P<0.01);术后1周、发生PDR-Ab感染时TCIFS的差异无统计学意义(P>0.05),但在治疗终点,免疫调节组的TCIFS明显高于常规治疗组(P<0.05);两组间治愈率的差异有统计学意义(P<0.05).2个组均未发生排斥反应.结论 肝移植后并发PDR-Ab感染时,根据T淋巴细胞亚群计数和CD4+T淋巴细胞ATP值对肝移植受者的细胞免疫功能进行量化评分,以进行免疫抑制方案的调整,是降低肝移植后PDR-Ab感染病死率的有效方法.
目的 探討肝移植後汎耐藥鮑曼不動桿菌(PDR-Ab)感染者的細胞免疫功能鑑測及免疫抑製方案的調整.方法 迴顧性總結2008年1月至2010年5月299例尸體肝移植病例併髮PDR-Ab的感染和預後情況.鑑測肝移植後T淋巴細胞亞群及絕對計數、CD4+T淋巴細胞ATP含量,進行T淋巴細胞免疫功能評分.將14例髮生PDR-Ab感染者根據免疫抑製方案的調整不同分為2組,常規治療組(6例)的他可莫司用量不變,停用嗎替麥攷酚酯和潑尼鬆,給予頭孢哌酮鈉/舒巴坦鈉靜脈滴註;免疫調節組(8例)在常規治療的基礎上,根據受者的T淋巴細胞免疫功能評分(TCIFS)的動態變化進行免疫抑製方案的調整.結果 兩組間受者的年齡、終末期肝病模型評分、Child-Pugh評分的差異均無統計學意義(P>0.05);術中齣血量的差異有統計學意義(P<0.01);術後1週、髮生PDR-Ab感染時TCIFS的差異無統計學意義(P>0.05),但在治療終點,免疫調節組的TCIFS明顯高于常規治療組(P<0.05);兩組間治愈率的差異有統計學意義(P<0.05).2箇組均未髮生排斥反應.結論 肝移植後併髮PDR-Ab感染時,根據T淋巴細胞亞群計數和CD4+T淋巴細胞ATP值對肝移植受者的細胞免疫功能進行量化評分,以進行免疫抑製方案的調整,是降低肝移植後PDR-Ab感染病死率的有效方法.
목적 탐토간이식후범내약포만불동간균(PDR-Ab)감염자적세포면역공능감측급면역억제방안적조정.방법 회고성총결2008년1월지2010년5월299례시체간이식병례병발PDR-Ab적감염화예후정황.감측간이식후T림파세포아군급절대계수、CD4+T림파세포ATP함량,진행T림파세포면역공능평분.장14례발생PDR-Ab감염자근거면역억제방안적조정불동분위2조,상규치료조(6례)적타가막사용량불변,정용마체맥고분지화발니송,급여두포고동납/서파탄납정맥적주;면역조절조(8례)재상규치료적기출상,근거수자적T림파세포면역공능평분(TCIFS)적동태변화진행면역억제방안적조정.결과 량조간수자적년령、종말기간병모형평분、Child-Pugh평분적차이균무통계학의의(P>0.05);술중출혈량적차이유통계학의의(P<0.01);술후1주、발생PDR-Ab감염시TCIFS적차이무통계학의의(P>0.05),단재치료종점,면역조절조적TCIFS명현고우상규치료조(P<0.05);량조간치유솔적차이유통계학의의(P<0.05).2개조균미발생배척반응.결론 간이식후병발PDR-Ab감염시,근거T림파세포아군계수화CD4+T림파세포ATP치대간이식수자적세포면역공능진행양화평분,이진행면역억제방안적조정,시강저간이식후PDR-Ab감염병사솔적유효방법.
Objective To explore the monitoring and the individualized adjustment of cellular immunology function in the recipients infected with pan-drug resistant Acinetobacter baumannii(PDR-Ab)after liver transplantation.Methods We retrospectively summarized the infection and the prognosis of PDR-Ab in 299 cases of liver transplantation performed from Jan.2008 to May 2010.The absolute number of T lymphocytes and ATP level within CD4+ T cells were monitored,and T cell immunology function(TCIFS)was scored.According to different immunology adjusting proposals,14 cases of PDR-Ab infection were divided into 2 groups:(1)traditional group,routine anti-infective therapy;(2)individualized group.Individualized immunology adjustment was made according to the score of TCIFS besides routine therapy.Results There was no significant difference in age,MELD and Child-pugh score between two groups.The peri-operative bleeding volume in individualized group was more than that in traditional group(P<0.01).There was no significant difference in TCIFS score between two groups at 1st week after transplantation and the onset of the PDR-Ab infection.However,the score in individualized group was apparently higher than that in traditional group when anti-infection therapy ended(P<0.05).The difference in the recovery rate between two groups was significant(P<0.05).No rejection happened in two groups.Conclusion It is an effective way to decrease the mortality of PDR-Ab infection after liver transplantation that the individualized adjustment of immunosuppression protocols is guided by grading quantitatively the cellular immunology function according to the absolute number of T lymphocytes and ATP level within CD4+ T cells.